Journey Medical Corporation Announces Upcoming Financial Results
Journey Medical Corporation, a thriving commercial-stage pharmaceutical company situated in Scottsdale, Arizona, is set to announce its financial performance for the third quarter of 2025. This eagerly anticipated announcement will occur after the markets close, specifically slated for November 12, 2025.
Conference Call Information
In conjunction with the release of the financial results, Journey Medical management is organizing a conference call and audio webcast to provide further insights into the Company’s performance and future directions. This event will take place on the same day at 4:30 p.m. ET, providing an opportunity for interested parties to engage with the management team.
To participate in the call, domestic attendees are encouraged to dial 1-866-777-2509, while international callers can reach the conference by calling 1-412-317-5413. It is advisable for participants to connect around ten minutes prior to the commencement of the call.
Accessing the Live Audio Webcast
For those unable to join the call directly, the audio webcast will be available on the News and Events page of the Investor section of Journey Medical’s official website. The replay of this discussion will remain accessible for approximately 30 days following the original presentation, ensuring that all stakeholders have the opportunity to review the insights shared during the call.
Exploring Journey Medical's Commitment to Dermatological Treatments
Journey Medical stands out in the pharmaceutical arena, dedicated to the selling and marketing of FDA-approved products aimed at treating a variety of dermatological issues. Their portfolio currently includes eight different branded prescription drugs, specifically designed to address common skin conditions, demonstrating their commitment to improving patients' lives.
Expertise and Experience in Dermatology
The team at Journey Medical comprises seasoned professionals who bring extensive knowledge and expertise in dermatology. Their combined efforts have led to the successful development and commercialization of numerous prescription brands recognized in the industry. This focus on specialized care has positioned Journey Medical as a leader within the sector, providing patients and healthcare providers with trusted solutions for skin health.
Company Background and Stock Information
Founded by Fortress Biotech, Inc., which is also publicly traded, Journey Medical Corporation operates under the ticker symbol Nasdaq: DERM. The Company’s strategies align with its goal of enhancing healthcare options through high-quality pharmaceutical products. Their transparency is upheld through regular filings with the U.S. Securities and Exchange Commission, allowing investors to remain informed about the Company's operations.
Company Contact Information
To ensure you have the correct contact for inquiries, Jaclyn Jaffe is the primary point of contact for shareholder questions. She can be reached at Journey Medical Corporation at (781) 652-4500. For media inquiries, Tony Plohoros of 6 Degrees is available for contact at (908) 591-2839. Both representatives are ready to assist with any further questions regarding Journey Medical and its operations.
Frequently Asked Questions
What financial results are being announced by Journey Medical?
Journey Medical is set to announce its third quarter financial results for 2025 on November 12, 2025.
How can I participate in the conference call?
To join the conference call, domestic callers should dial 1-866-777-2509, while international participants can use 1-412-317-5413. It's recommended to call in ten minutes early.
Where can I find the audio webcast?
The audio webcast will be available on the News and Events page of Journey Medical’s official website, remaining accessible for about 30 days after the call.
What does Journey Medical focus on?
Journey Medical specializes in marketing and selling FDA-approved prescription medications for dermatological conditions.
Who can I contact for more information about Journey Medical?
Jaclyn Jaffe is the point of contact for shareholders, while Tony Plohoros handles media inquiries. Their contact information is available for those seeking additional details.
